These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2450757)
1. Effect of HgCl2 on experimental allergic encephalomyelitis in Lewis rats. HgCl2-induced down-modulation of the disease. Pelletier L; Rossert J; Pasquier R; Villarroya H; Belair MF; Vial MC; Oriol R; Druet P Eur J Immunol; 1988 Feb; 18(2):243-7. PubMed ID: 2450757 [TBL] [Abstract][Full Text] [Related]
2. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides. Raziuddin S; Kibler RF; Morrison DC J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621 [TBL] [Abstract][Full Text] [Related]
3. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2. Jung S; Toyka K; Hartung HP Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758 [TBL] [Abstract][Full Text] [Related]
4. Complete Freund's adjuvants (CFA) induced unresponsiveness to EAE in Lewis rats. Hempel K; Freitag A; Freitag B; Endres B; Mai B Prog Clin Biol Res; 1984; 146():407-14. PubMed ID: 6201910 [No Abstract] [Full Text] [Related]
5. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis. Vandenbark AA; Gill T; Offner H J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032 [TBL] [Abstract][Full Text] [Related]
6. Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity. Willenborg DO; Staykova MA; Miyasaka M J Immunol; 1996 Sep; 157(5):1973-80. PubMed ID: 8757317 [TBL] [Abstract][Full Text] [Related]
7. A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis. Ellerman KE; Powers JM; Brostoff SW Nature; 1988 Jan; 331(6153):265-7. PubMed ID: 2447505 [TBL] [Abstract][Full Text] [Related]
8. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant. Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517 [TBL] [Abstract][Full Text] [Related]
9. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant. Holda JH; Silberg D; Swanborg RH J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402 [TBL] [Abstract][Full Text] [Related]
10. Recovery of myelin basic protein reactive T cells from spinal cords of Lewis rats with autoimmune encephalomyelitis. Burns J; Rosenzweig A; Zweiman B; Moskovitz A; Lisak R J Immunol; 1984 Jun; 132(6):2690-2. PubMed ID: 6202757 [TBL] [Abstract][Full Text] [Related]
11. Suppressor cells in Lewis rats with experimental allergic encephalomyelitis: prevention of the disease and inhibition of lymphocyte proliferation by the suppressor cells or their products. Beraud E; Varriale S; Farnarier C; Bernard D Eur J Immunol; 1982 Nov; 12(11):926-30. PubMed ID: 6217977 [TBL] [Abstract][Full Text] [Related]
12. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease. Welch AM; Holda JH; Swanborg RH J Immunol; 1980 Jul; 125(1):186-9. PubMed ID: 6155396 [TBL] [Abstract][Full Text] [Related]
13. Experimental allergic encephalomyelitis in Lewis rats: inhibition by bacterial lipopolysaccharides and acquired resistance to reinduction by challenge with myelin basic protein. Raziuddin S; Kibler RF; Morrison DC J Immunol; 1981 Jul; 127(1):16-20. PubMed ID: 6165759 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Gold DP; Schroder K; Powell HC; Kelly CJ Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811 [TBL] [Abstract][Full Text] [Related]
15. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats. Holda JH; Swanborg RH Eur J Immunol; 1981 Apr; 11(4):338-40. PubMed ID: 6166483 [TBL] [Abstract][Full Text] [Related]
16. The response of the nude (athymic) rat to actively induced and adoptively transferred experimental allergic encephalomyelitis. Hinrichs DJ; Humphres RC J Immunol; 1983 Jul; 131(1):4-5. PubMed ID: 6190918 [No Abstract] [Full Text] [Related]
17. Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines. Ben-Nun A; Cohen IR J Immunol; 1982 Mar; 128(3):1450-7. PubMed ID: 6173439 [No Abstract] [Full Text] [Related]
18. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction. O'Brien NC; Charlton B; Cowden WB; Willenborg DO J Immunol; 1999 Dec; 163(12):6841-7. PubMed ID: 10586085 [TBL] [Abstract][Full Text] [Related]
19. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560 [TBL] [Abstract][Full Text] [Related]
20. Autoimmune effector cells. V.A monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of autoimmune encephalomyelitis. Swanborg RH J Immunol; 1983 Apr; 130(4):1503-5. PubMed ID: 6187808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]